https://cdn.explara.com/public/v_10.0/internal-flow/img/event-landing/default_header_img.png
Counterfeits & Spurious Drugs - Opportunities for Startu...
Aug 7, 2020
05:00 PM - 07:00 PM (Asia/Kolkata)

This event has ended. Please contact organizer for more details.

Report Issues

Every country, including India, is a victim of spurious drugs and counterfeits, which overall effects the health system across the globe. Many middle eastern countries and other countries such as Brazil, Mexico, China, India, Russia and Pakistan are considered to be some of the main distributors of spurious drugs in the world. 

In this webinar, our distinguished panel will take us through the practical aspects along with the underlying problem and causes of the spread of spurious drugs and counterfeits. The webinar would also enumerate the measures adopted by the Indian Pharmaceutical Industry to combat the spread of spurious drugs, whilst providing opportunities to startups to provide solutions to combat this piracy.

Panelists:

  • Annaswamy Vaidheesh, CEO, North Star Asia LLP; Ex Managing Director, GSK Pharmaceuticals; ex President, OPPI
  • Dr. Karthik Anantharaman, Director - e-Pharmacy & Private Label Business, Medlife.com
  • Dr. Subir Basak, ex CEO, Intas Biopharmaceuticals; TiE Charter Member (Moderator)
  • Suryanarayanan A., Governing Board Member, TiE Bangalore; Independent Consultant to Startups
  • Venkata Raghavan, Proprietor, Escalade Legal Services; TiE Charter Member


Reviews

Organiser : TiE Bangalore

TiE Bangalore

TiE is powered by Explara. Explara uses cookies to enhance your experience. By using our site, you agree to our privacy policy.

Counterfeits & Spurious Drugs - Opportunities for Startups to Resolve during Covid-19

Ask Organiser

Report spam or issues